Hypothesis
Version 1
This version is not peer-reviewed
Autoimmune Thrombotic Thrombocytopathy Associated with COVID-19 Infection or Vaccination: Learning from Heparin-induced Thrombocytopenia
Version 1
: Received: 8 April 2021 / Approved: 9 April 2021 / Online: 9 April 2021 (10:13:14 CEST)
Version 2 : Received: 15 April 2021 / Approved: 15 April 2021 / Online: 15 April 2021 (14:05:48 CEST)
Version 2 : Received: 15 April 2021 / Approved: 15 April 2021 / Online: 15 April 2021 (14:05:48 CEST)
How to cite: Goldman, M. Autoimmune Thrombotic Thrombocytopathy Associated with COVID-19 Infection or Vaccination: Learning from Heparin-induced Thrombocytopenia. Preprints 2021, 2021040255 Goldman, M. Autoimmune Thrombotic Thrombocytopathy Associated with COVID-19 Infection or Vaccination: Learning from Heparin-induced Thrombocytopenia. Preprints 2021, 2021040255
Abstract
Prothrombotic thrombocytopathy mimicking heparin-induced thrombocytopenia has been observed in patients with severe COVID-19 and after immunisation with the Vaxzevria vaccine. Herein, we discuss the possible pathogenesis of this disorder focusing on the possible involvement of anti-platelet factor 4 (PFA) autoantibodies.
Keywords
COVID-19; vaccine; heparin; thrombocytopenia; thrombosis; platelet; endothelial cell; autoimmunity; proteoglycan; B cell; coagulation
Subject
Medicine and Pharmacology, Immunology and Allergy
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment